右前庭心脏血管瘤:从症状到手术的多学科途径
Jade Gourmelon1, Valentin Loobuyck1, Valentina Silvestri2
1Department of Cardiac Surgery, University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.
JACC. Case reports
|January 17, 2025
概括
一种罕见的心脏毛细血管血管瘤在一名76岁的老人身上引起了右心力衰竭. 突出了像这种血管瘤这样的内心质量定位的先进成像挑战.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 诊断成像 诊断成像 诊断成像
背景情况:
- 右心力衰竭可能源于各种原因,包括心内质量.
- 心脏瘤很少见,血管瘤是一种不常见的亚型.
- 准确地定位和描述心脏质量对于诊断和治疗计划至关重要.
研究的目的:
- 报告心脏内毛细血管血管瘤的次要性右心衰竭的新发病例.
- 为了说明与罕见的心脏质量相关的诊断挑战,尽管有先进的成像技术.
- 强调手术确认对于确定诊断的重要性.
主要方法:
- 一名76岁的男性患者出现了新发右心力衰竭.
- 多模式心脏成像,包括心声学和正子发射断层扫描 (PET) 扫描.
- 通过右前部小型胸腔切除手术切除心内质量.
主要成果:
- 心声检查发现右心房附近有一块质量,但其确切位置尚不清楚.
- 佩特扫描显示了高代谢活动,这表明血管瘤.
- 对切除的体质进行了组织病理学检查,证实了毛细血管血管瘤.
结论:
- 心脏毛细血管血管瘤可以呈现为右心力衰竭.
- 先进的成像方法在精确地定位和表征罕见心内质量方面仍然可能面临挑战.
- 手术切除对于确诊和管理这种罕见的心脏瘤至关重要.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


